82
Participants
Start Date
February 28, 2006
Primary Completion Date
December 31, 2012
Study Completion Date
October 15, 2014
cisplatin
Given IV
irinotecan hydrochloride
Given IV
therapeutic conventional surgery
Undergo Surgery
radiation therapy
Undergo radiation
Memorial Sloan-Kettering Cancer Center, New York
SUNY Upstate Medical University Hospital, Syracuse
Veterans Affairs Medical Center - Buffalo, Buffalo
Wayne Memorial Hospital, Incorporated, Goldsboro
Center for Cancer Therapy at LaPorte Hospital and Health Services, La Porte
Elkhart General Hospital, Elkhart
CCOP - Northern Indiana CR Consortium, South Bend
Memorial Hospital of South Bend, South Bend
Michiana Hematology-Oncology, PC - South Bend, South Bend
Howard Community Hospital, Kokomo
Lakeland Regional Cancer Care Center - St. Joseph, Saint Joseph
Methodist Estabrook Cancer Center, Omaha
Saint Joseph Regional Medical Center, Mishawaka
Holden Comprehensive Cancer Center at University of Iowa, Iowa City
CancerCare of Maine at Eastern Maine Medical Center, Bangor
Maine Center for Cancer Medicine and Blood Disorders - Scarborough, Scarborough
New Hampshire Oncology - Hematology, PA at Payson Center for Cancer Care, Concord
New Hampshire Oncology - Hematology, PA - Hooksett, Hooksett
Lakes Region General Hospital, Laconia
Elliot Regional Cancer Center at Elliot Hospital, Manchester
Roswell Park Cancer Institute, Buffalo
Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center, Columbus
Mountainview Medical, Berlin Corners
Fletcher Allen Health Care - University Health Center Campus, Burlington
National Cancer Institute (NCI)
NIH
Alliance for Clinical Trials in Oncology
OTHER